Bioeconomy Capital's Rob Carlson sees big potential in Seattle's industrial biotech startups

The emerging industry had a U.S. market potential of at least $150 billion in 2016, the venture capital firm's co-founder said.

Source: bizjournals.com Health Care:Physician Practices headlines - December 13, 2017 Category: American Health Authors: Casey Coombs Source Type: news